Healthy volunteers help test new drug's effect on two common medications
NCT ID NCT07215260
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how a new drug called BI 3000202 changes the way the body handles two other medicines: rosuvastatin (for cholesterol) and digoxin (for heart conditions). Fourteen healthy adults took part to help researchers understand if the new drug could affect how these medications work. The results will guide future dosing recommendations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Humanpharmakologisches Zentrum Biberach
Biberach, 88397, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Could everyday disinfectants be harming us? a new study investigates
- Can a new drug keep the Heart's beat steady? trial puts verducatib to the test